MIDDLE CHARE MEDICAL GROUP — All Prescriptions & Medications — Page 9
Practice Code: A83028 | CHESTER LE STREET, DH3 3QD
Showing results 401-450 of 647
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder amino acid formula (0913107) | 40 | 143.6K | £9.1K | +21.1% ▲ |
| Ipratropium bromide | 40 | 48 | £344 | +146.7% ▲ |
| 40 | 557 | £826 | -9.0% ▼ | |
| 40 | 136 | £833 | +43.8% ▲ | |
| Valsartan | 39 | 1,652 | £377 | -33.8% ▼ |
| Etodolac | 39 | 1,230 | £604 | +40.9% ▲ |
| 39 | 1,151 | £5.8K | +313.1% ▲ | |
| Phosphates (Rectal) | 38 | 943 | £3.1K | +210.9% ▲ |
| Modafinil | 38 | 2,540 | £300 | +82.2% ▲ |
| Alogliptin | 38 | 1,064 | £961 | -85.0% ▼ |
| Sodium fluoride | 38 | 3,372 | £326 | +14.5% ▲ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 38 | 133.6K | £1.9K | -0.4% vs avg |
| 38 | 8,440 | £131 | +124.9% ▲ | |
| Cocois | 37 | 4,000 | £599 | +169.5% ▲ |
| Indacaterol/glycopyrronium | 36 | 1,080 | £1.1K | -20.3% ▼ |
| 36 | 1,765 | £1.3K | -3.0% ▼ | |
| 36 | 1,950 | £3.3K | +70.0% ▲ | |
| Alverine citrate | 35 | 3,258 | £308 | -15.4% ▼ |
| Rifaximin | 35 | 1,407 | £6.5K | +30.4% ▲ |
| Testosterone undecanoate | 35 | 52 | £4.5K | +37.8% ▲ |
| Tacrolimus | 35 | 1,290 | £920 | -35.1% ▼ |
| Oxcarbazepine | 34 | 2,132 | £450 | +21.6% ▲ |
| Rotigotine | 34 | 952 | £3.8K | +26.0% ▲ |
| Magnesium aspartate | 34 | 1,230 | £1.1K | +124.5% ▲ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 34 | 112.0K | £681 | +68.1% ▲ |
| Benzydamine hydrochloride | 34 | 3,705 | £95 | -56.0% ▼ |
| 34 | 1,635 | £3.2K | +305.8% ▲ | |
| Fluticasone furoate/vilanterol | 33 | 38 | £795 | -78.7% ▼ |
| Isophane insulin | 33 | 210 | £908 | -68.7% ▼ |
| Acetic acid | 33 | 180 | £169 | +184.9% ▲ |
| Urea | 33 | 10.2K | £379 | -50.6% ▼ |
| 33 | 33 | £78 | +1.8% vs avg | |
| Enoxaparin | 32 | 679 | £3.2K | +56.1% ▲ |
| Haloperidol | 32 | 1,098 | £228 | -32.8% ▼ |
| Tirzepatide | 32 | 32 | £3.0K | -83.5% ▼ |
| Triptorelin embonate | 32 | 32 | £12.3K | +221.4% ▲ |
| Chlorhexidine gluconate | 32 | 14.1K | £246 | +8.4% ▲ |
| Midazolam hydrochloride | 32 | 310 | £207 | -21.8% ▼ |
| 32 | 480 | £1.3K | -1.8% vs avg | |
| 32 | 3,100 | £446 | +0.8% vs avg | |
| Glucagon | 31 | 43 | £1.5K | +103.8% ▲ |
| Metronidazole | 31 | 1,320 | £490 | -17.5% ▼ |
| 31 | 14.3K | £209 | -66.0% ▼ | |
| Cimetidine | 30 | 1,314 | £130 | +60.8% ▲ |
| Inclisiran | 30 | 30 | £1.4K | +138.1% ▲ |
| Codeine phosphate | 30 | 9,900 | £188 | +109.0% ▲ |
| Drospirenone | 30 | 1,652 | £277 | +366.2% ▲ |
| Exemestane | 30 | 1,016 | £180 | -7.7% ▼ |
| Mefenamic acid | 30 | 1,986 | £423 | -33.6% ▼ |
| 30 | 3,060 | £5.0K | +70.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.